In a new study published in The Lancet Diabetes & Endocrinology, metformin use is associated with significantly increased all-cause mortality in patients with type 2 diabetes mellitus and stage 5 chronic kidney disease (CKD). The findings support current recommendations that metformin should not be used in patients with stage 5 CKD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/nrendo.2015.132 | DOI Listing |
Publication Analysis
Top Keywords
metformin patients
8
therapy risk
4
risk metformin
4
patients t2dm
4
t2dm advanced
4
advanced ckd
4
ckd study
4
study published
4
published lancet
4
lancet diabetes
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!